Generation and Characterization of a Human/Mouse Chimeric GD2-Mimicking Anti-Idiotype Antibody Ganglidiximab for Active Immunotherapy against Neuroblastoma.
Vaccination with proteins mimicking GD2 that is highly expressed on neuroblastoma (NB) cells is a promising strategy in treatment of NB, a pediatric malignancy with poor prognosis. We previously showed efficacy of ganglidiomab in vivo, a murine anti-idiotype (anti-Id) IgG1. In order to tailor immune...
Saved in:
| Main Authors: | Christin Eger, Nikolai Siebert, Diana Seidel, Maxi Zumpe, Madlen Jüttner, Sven Brandt, Hans-Peter Müller, Holger N Lode |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0150479&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GD2 targeting CAR T cells for neuroblastoma
by: John Anderson, et al.
Published: (2024-12-01) -
Anti-Idiotype Antibodies for the Diagnosis of Infectious Diseases
by: Bernard R Brodeur, et al.
Published: (1992-01-01) -
Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma
by: Jourdin R. C. Rouaen, et al.
Published: (2024-12-01) -
Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases
by: Shing Yi Pan, et al.
Published: (2021-02-01) -
Near-infrared photoimmunotherapy using antiGD2 antibody for neuroblastoma and osteosarcoma
by: Jimei Zhao, et al.
Published: (2025-06-01)